Many patients with CS display clinical signs of systemic inflammation2 and elevated plasma levels of prototypical inflammatory mediators, such as C-reactive protein (CRP), Interleukin-6 (IL-6) and tumor necrosis alpha (TNFα)3,4. This evidence concerns the gene IL6 and Cowden syndrome 1.